NY Open: Drugs can’t ease Wall Street’s Apple fears

Equities 4 minutes to read

Summary:  Traders may have dismissed the Asia “Twilight Zone Flash Crash” as just an anomaly in an extremely thin market, but even a big-ticket pharma takeover hasn't brightened the mood much.


Echo’s from Apple’s (AAP: Nasdaq) bombshell earnings forecast downgrade reverberated on Wall Street this morning. The Dow Jones Industrial Average opened in negative territory and had dropped 1.43% by 14:00 GMT. The S&P 500 followed suit, losing 1.44% while the Nasdaq shed 1.92%.  

What do you do if you have an extra $34.8 billion in cash lying around? If you are Bristol Meyers Squibb (BMY: NYSE), you buy (merge) with Celgene Corporation (CELG: Nasdaq). BMY: NYSE announced that it had entered into a definitive merger agreement with CELG: Nasdaq for $50.00 per share in cash and one BMY share. The press release touts compelling strategic and financial benefits as the rationale for the deal. CELG shareholders were impressed, and the stock rose 27.8% at the open. BMY shareholders were not nearly as thrilled, and that share price dropped 12.30% in early New York trading.

New York traders appear to have dismissed the Asia “Twilight Zone Flash Crash” as just an anomaly in an extremely thin market, one that is notorious for dramatic and unjustified price activity. The commodity bloc currencies are higher than where they closed as are EUR and the Swiss franc. USDJPY is the laggard as falling US Treasury yields weigh on the currency.

The US dollar is being undermined by mixed to soft economic data. The fickle ADP employment report surprised to the topside while the more important ISM Manufacturing PMI for December disappointed.

USDCAD appears to have re-correlated itself with West Texas Intermediate prices dropping from an overnight peak of 1.3657 to 1.3509 after the ISM report.  WTI rallied from an overnight low of $45.39/barrel to $$7.47/b before falling back to $46.58 in NY. Traders are encouraged by the double bottom at $42.60/b, an improved dialogue to the US/China trade talks and the onset of the Opec production cuts.
Chart: USDCAD 30 minute with WTI oil.     Source: Saxo Bank
Disclaimer

Saxo Capital Markets (Australia) Pty Ltd prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Combined Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at https://www.home.saxo/en-au/legal/.

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

Please read our disclaimers:
- Full Disclaimer (https://www.home.saxo/en-au/legal/disclaimer/saxo-disclaimer)
- Analysis Disclaimer (https://www.home.saxo/en-au/legal/analysis-disclaimer/saxo-analysis-disclaimer)
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)

Saxo Capital Markets (Australia) Pty Ltd.
Level 25, 2 Park Street
NSW 2000
Sydney
Australia

Australia

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-au/about-us/awards

Saxo Capital Markets (Australia) Pty Ltd ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Combined Financial Services Guide & Product Disclosure Statement to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as CFDs and Margin FX products may result in your losses surpassing your initial deposits. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.
Please click here to view our full disclaimer.